ALEXION PHARMACEUTICALS

ALEXION PHARMACEUTICALS

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq for patients with hypophosphatasia; Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lip... ase deficiency; and Andexxa, a reversal agent for patients treated with rivaroxaban or apixaban. In addition, the company is developing ALXN1210 (Intravenous) that is in Phase III clinical trials for the treatment of gMG, NMOSD, ALS, COVID-19, and HSCT-TMA; ALXN1210 (Subcutaneous), which is in Phase III clinical trials for PNH and aHUS; ALXN1820 that is in Phase I clinical trial, a therapeutic antagonist of properdin; and ALXN1720, which is in Phase I clinical trial for the treatment of disease states involving dysregulated terminal complement activity. Further, it is developing ALXN1840 that is in Phase III clinical trials for the treatment of Wilson disease; ALXN1830, which are in Phase I clinical trials for neonatal Fc receptor; ALXN2040 and ALXN2050 to treat diseases associated with dysregulation of the complement alternative pathway; ALXN1850, an enzyme replacement therapy; ALXN2060 for treating transthyretin amyloidosis; and ALXN2075 for treatment of relapsed/refractory chronic lymphocytic leukemia. The company serves distributors, pharmacies, hospital, hospital buying groups, and other healthcare providers in the United States and internationally. Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; and agreements with Dicerna Pharmaceuticals, Inc., Zealand Pharma A/S, Caelum Biosciences, Inc., Stealth BioTherapeutics Corp., and Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts.

Alexion Pharmaceuticals_logo

Industry:
American Pharmaceutical Company

Address:
121 Seaport Boulevard, Boston, MA, United States Zipcode 02210

Country:
United States

Phone:
475 230 2596

Market Cap:
33.86B
Total Revenue:
6.07B
Total Assets:
18.1B
Total Cash:
2.96B

Subsidiaries: Alexion Pharma UK · Alexion Bermuda LP · Alexion Antibody Technologies, Inc · Alexion Pharma Spain SL · Alexion Pharma KK · Alexion Pharma France · Alexion Pharma Germany GmbH · Alexion Pharmaceuticals Australiasia PTY LTD · Alexion Pharma Suisse Sarl · Alexion Pharma Italy S.r.l · Alexion International Sarl · Alexion Pharma …

Corporate leaders

Ludwig Hantson, Ph.d._image

Ludwig Hantson, Ph.d.
CEO

Aradhana Sarin, M.d._image

Aradhana Sarin, M.d.
Executive VP, CFO

Tanisha Carino, Ph.d._image

Tanisha Carino, Ph.d.
Executive VP


Key Executives
Name Title Pay Year Born
Dr. Ludwig N. Hantson CEO & Director 4,248,900$ 1963(57 years old)
Dr. Aradhana Sarin M.D. Exec. VP & CFO 1,751,200$ 1975(45 years old)
Mr. Brian M. Goff Exec. VP and Chief Commercial & Global Operations Officer 1,763,085$ 1969(51 years old)
Ms. Ellen V. Chiniara J.D., Esq. Exec. VP, Chief Legal Officer & Corp. Sec. 1,564,643$ 1959(61 years old)
Dr. John J. Orloff Exec. VP and Head of R&D 1,832,066$ 1957(63 years old)
Mr. Daniel A. Bazarko CPA Chief Accounting Officer & Sr. VP N/A N/A
Mr. Christopher J. Stevo CFA Head of Investor Relations N/A N/A
Ms. Indrani M. Lall Franchini Exec. VP & Chief Compliance Officer N/A 1972(48 years old)
Megan Goulart Sr. Director of Corp. Communications N/A N/A
Ms. Becky Lillie Interim Chief Human Experience Officer N/A N/A



Financial & Stock
Exchange NasdaqGS. Currency in USD. Market state PREPRE
According to Alexion Pharmaceuticals's financial reports the company's revenue in 2020 were 6.07B an increase( +50%) over the years 2019 revenue that were of 4.99B. In 2020 the company's total earnings were 603.4M while total earnings in 2019 were 2.4B(-69.85%).
Company's stock symbol is ALXN. Lastest price : 154.01. Total volume :2.41M Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.alexion.com

  • Host name: server-13-225-210-69.ewr50.r.cloudfront.net
  • IP address: 13.225.210.69
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...
Loading ...


More informations about "Alexion Pharmaceuticals" on Search Engine

Alexion

Alexion.com Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.

Alexion

Alexion.com Alexion delivers therapies for people living with rare and devastating diseases. Learn about …

Alexion

Alexion.com At Alexion, our passion drives us to continuously innovate and create …

Alexion

Alexion.com Alexion is committed to collaborating with researchers on innovative projects that …

Alexion

Alexion.com Alexion is collaborating with Caelum Biosciences to develop CAEL-101 for light …

Alexion

Alexion.com The Investor Relations website contains information about Alexion Pharmaceuticals, …

Alexion

Alexion.com COVID-19 Update. At Alexion, we commit ourselves every day to delivering on our …

Alexion Pharmaceuticals - Wikipedia

En.wikipedia.org Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases. It employs around 2,400 people worldwide. In February 2016, the company held the dedication ceremony for its new headquarters in New Haven, Connecticut, not far from the company…

Alexion Pharmaceuticals (ALXN) - Forbes

Forbes.com Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of...

Alexion (ALXN) to Be Acquired by AstraZeneca for $39

Nasdaq.com Dec 14, 2020 · Alexion Pharmaceuticals, Inc. ALXN entered into a definitive agreement with U.K.-based pharmaceutical company, AstraZeneca plc AZN, …

AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion

Fool.com Dec 13, 2020 · Despite the COVID-19 pandemic, sales of Alexion's rare disease drugs didn't skip a beat in 2020. In fact, they're significantly outperforming expectations the company laid out in January....

SEC.gov | SEC Charges Alexion Pharmaceuticals With FCPA

Sec.gov Jul 02, 2020 · Washington D.C., July 2, 2020 — The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA).

ALXN Stock Price | Alexion Pharmaceuticals Inc. Stock

Marketwatch.com Apr 09, 2021 · Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization...

AstraZeneca to buy Alexion for $39 billion to expand in

Cnbc.com Dec 12, 2020 · Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in its largest-ever deal, diversifying away from its fast-growing cancer business in a …

AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion

Barrons.com Dec 13, 2020 · Alexion is known for its development of rare disease drugs Ultomiris and Soliris, which together accounted for $4.3 billion of Alexion’s $5 billion in product sales in 2019. Alexion …

Alexion Pharmaceuticals, Inc. (ALXN) Stock Price, News

Finance.yahoo.com Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to AstraZeneca PLC for $60.00 in...

Alexion Pharmaceuticals, Inc. | LinkedIn

Linkedin.com About us At Alexion, our mission is to transform the lives of people living with rare and devastating diseases through the development and delivery of innovative medicines, as well as through...

Working at Alexion Pharmaceuticals,Inc.: 115 Reviews

Indeed.com Very smart people work at Alexion Pharmaceuticals. Most are very polite and professional. It was the facilities management I would recommend they improve, as a temp I was often told to do things outside of my job description (which I am okay with) but in a frequently condescending manner, I was called dumb by my own manager for one of his mistakes and was constantly overhearing much about ...

Alexion Pharmaceuticals, Inc. 8-K Mar. 15, 2021 4:10 PM

Seekingalpha.com ALEXION PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) 121 Seaport Boulevard, Boston, Massachusetts 02210 (Address of Principal Executive Offices) (Zip Code)

Alexion is bought by Covid-19 vaccine developer

Cnn.com Dec 13, 2020 · Leading Covid-19 vaccine developer AstraZeneca agreed on Saturday to buy Boston pharmaceutical firm Alexion for $39 billion.

Alexion Careers Job Search Results

Jobs.alexion.com Alexion is a leading rare disease company with approximately 3,000 dedicated employees around the world serving patients in 50 countries.

Alexion Pharmaceuticals: Growth At A Reasonable Price

Seekingalpha.com Jul 11, 2020 · “Based in New Haven, CT, Alexion Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of life-transforming drugs, for …

ALXN Stock Forecast, Price & News (Alexion Pharmaceuticals)

Marketbeat.com Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; and agreements with Dicerna Pharmaceuticals, Inc., Zealand Pharma A/S, Caelum Biosciences, Inc., Stealth BioTherapeutics Corp., and Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts.

Dear Communities | Alexion 2020 CSR Report

Csr.alexion.com At Alexion, we take a comprehensive view of corporate social responsibility (CSR), which encompasses environmental, social and governance topics that impact our business and our stakeholders. This website provides a summary of our CSR efforts throughout 2020.

Why AstraZeneca Wants To Buy Alexion Pharmaceuticals

Forbes.com Dec 14, 2020 · Alexion has been on an acquisition spree. It has spent nearly $4 billion in the last 2-3 years acquiring several drug companies. Considering that the pharma …

ALXN: Alexion Pharmaceuticals Inc - Stock Price, Quote and

Cnbc.com Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products.

AstraZeneca to acquire Alexion, accelerating the Company's

Astrazeneca.com Dec 12, 2020 · AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion …

Big Pharma Deals: AstraZeneca Buying Alexion

Bloomberg.com Dec 12, 2020 · Alexion Pharmaceuticals Inc. for $39 billion in cash and shares, adding a specialist in the treatment of rare diseases and immunology to its portfolio of …

88 Alexion Pharmaceuticals Jobs, Employment | Indeed.com

Indeed.com 88 Alexion Pharmaceuticals jobs available on Indeed.com. Apply to Communications Intern, Patient Advocate, Operations Intern and more!

Alexion Pharmaceuticals Reviews | Glassdoor

Glassdoor.com Apr 06, 2021 · 235 Alexion Pharmaceuticals reviews. A free inside look at company reviews and salaries posted anonymously by employees.

Activist investor Elliott pushes Alexion Pharma to sell

Reuters.com Hedge fund Elliott Management on Tuesday publicly called on Alexion Pharmaceuticals Inc to sell itself, arguing that management's steps, including recent plans to acquire a smaller company, were ...

Alexion Pharmaceuticals, Inc. (ALXN) Valuation Measures

Finance.yahoo.com Find out all the key statistics for Alexion Pharmaceuticals, Inc. (ALXN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Alexion Pharmaceuticals Salaries | Glassdoor

Glassdoor.com Apr 05, 2021 · Alexion Pharmaceuticals employees rate the overall compensation and benefits package 4.4/5 stars. What is the highest salary at Alexion Pharmaceuticals? The highest-paying job at Alexion Pharmaceuticals is Exec Director, Commercial for a salary of $327,731 per year.

Alexion's (@alexionpharmaceuticals) Instagram profile

Instagram.com 1,894 Followers, 32 Following, 449 Posts - See Instagram photos and videos from Alexion (@alexionpharmaceuticals)

Alexion Pharmaceuticals Company Profile - Office Locations

Craft.co Dec 06, 2019 · Alexion Pharmaceuticals has 3,082 employees across 23 locations and $6.07 B in annual revenue in FY 2020. See insights on Alexion Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Alexion Pharmaceuticals: Number of Employees 2006-2020

Macrotrends.net Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies.

Development Job in New Haven, CT at Alexion Pharmaceuticals

Ziprecruiter.com Alexion Pharmaceuticals. Address New Haven, CT. 06532 USA. Industry. Science. View all jobs at Alexion Pharmaceuticals Report Job. Report Job. Select a reason for reporting this job. This job is offensive or discriminatory This job appears to be fake This job …

Scientist Job in Boston, MA at Alexion Pharmaceuticals

Ziprecruiter.com Alexion Pharmaceuticals. Address Boston, MA. 02133 USA. Industry. Healthcare. View all jobs at Alexion Pharmaceuticals Report Job. Report Job. Select a reason for reporting this job. This job is offensive or discriminatory This job appears to be fake This job …

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Expected to

Marketbeat.com Apr 06, 2021 · Alexion Pharmaceuticals has a 12 month low of $90.55 and a 12 month high of $162.60. The company has a market capitalization of $33.88 billion, a P/E ratio of 36.01, a PEG ratio of 0.75 and a beta of 1.33. Alexion Pharmaceuticals Company Profile. Alexion Pharmaceuticals, Inc develops and commercializes various therapeutic products.

Alexion Pharmaceuticals - Home | Facebook

Facebook.com Alexion Pharmaceuticals, Boston, Massachusetts. 559 likes · 34 talking about this · 2 were here. Our mission is to transform the lives of people affected by rare and devastating diseases by...

20 Best alexion pharmaceuticals jobs (Hiring Now)

Simplyhired.com 77 alexion pharmaceuticals jobs available. See salaries, compare reviews, easily apply, and get hired. New alexion pharmaceuticals careers are added daily on SimplyHired.com. The low-stress way to find your next alexion pharmaceuticals job opportunity is on SimplyHired. There are over 77 alexion pharmaceuticals careers waiting for you to apply!

Alexion Pharmaceuticals Salaries - Zippia

Zippia.com Aug 27, 2020 · While Alexion Pharmaceuticals employees earn an average yearly salary of $86,316, different roles can command different wages. Some of the positions that earn high wages at Alexion Pharmaceuticals include senior director, medical science liaison, director of technology and services, and clinical specialist.

ALXN: Dividend Date & History for Alexion Pharmaceuticals

Dividend.com Alexion Pharmaceuticals, Inc. (ALXN) Payout Estimation Logic Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included.

Alexion Pharmaceuticals - Home | Facebook

Facebook.com Alexion Pharmaceuticals, Boston, Massachusetts. 560 likes · 16 talking about this · 2 were here. Our mission is to transform the lives of people affected by rare and devastating diseases by...

Alexion Pharmaceuticals Revenue 2006-2020 | ALXN | MacroTrends

Macrotrends.net Alexion Pharmaceuticals annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Subsidiaries of Alexion Pharmaceuticals, Inc.

Sec.gov Alexion Pharmaceuticals Australasia PTY LTD is incorporated in Australia . Alexion Pharma Belgium Sarl is incorporated in Belgium . Alexion Farmacêutica Brasil Importação e Distribuição de Produtos e Serviços de Administração de Vendas Ltda. (doing business as Alexion Brasil) is …

Alexion Pharmaceuticals: Technology enables more talent

Blog.box.com Alexion Pharmaceuticals has always been on the forefront of fighting rare (and ultra rare) diseases that devastate people’s lives. Now, the company has joined the fight to solve the current global health crisis. Alexion scientists are engaged in Phase 3 of a clinical trial for a new COVID-19 therapy called ULTOMIRIS®. As CIO, George Llado supports state-of-the-art therapy development by ...

AstraZeneca stock tumbles as Alexion shares soar after

Marketwatch.com Dec 14, 2020 · The cash and stock deal, the largest in AstraZeneca’s AZN, -1.03% history, values Alexion ALXN, +0.20% at $175 per share and has been agreed upon by …

Alexion Pharmaceuticals 100 College St New Haven, CT

Mapquest.com Alexion Pharmaceuticals 100 College St New Haven CT 06510. Reviews (203) 272-2596. Menu & Reservations Make Reservations . Order Online Tickets Tickets See Availability Directions {{::location.tagLine.value.text}} Sponsored Topics. Legal. Help Get directions, reviews and information for Alexion Pharmaceuticals in New Haven, CT. ...

Alexion CoPay Program

Alexiononesource.com Alexion OneSource CoPay Program Terms and Conditions The Alexion OneSource™ Copay Program (the “Program”) pays for eligible out-of-pocket medication and infusion costs associated with Soliris ® (eculizumab) or ULTOMIRIS ® (ravulizumab-cwvz) up to $15,000 US dollars

Is Alexion Pharmaceuticals a Buy? - MSN

Msn.com Apr 10, 2020 · There are plenty of promising biotech stocks for investors to sift through right now. One of these companies is Alexion Pharmaceuticals (NASDAQ: ALXN), a developer of …